Private Equity

Healthcare

Vesey Street collects over $136 mln for healthcare fund

Vesey Street Capital Partners has raised over $136 million for its healthcare fund, according to an SEC filing. The target is $250 million.

1 min read · 22 August 2018

IPM garners funding from Court Square

Court Square Capital Partners has made an investment in Fresno, California-based Integrated Prescription Management, a pharmacy benefit manager. No financial terms were disclosed. Covington Associates LLC and Foley Hoag LLP advised IPM on the transaction.

2 min read · 21 August 2018

PE-backed Care Advantages acquires two home care providers

Care Advantage Inc, a portfolio company of BelHealth Investment Partners LLC, has made two Richmond, Virginia-based acquisitions: Paradise Homecare, a provider of in-home skilled nursing services; and A Hopeful Home, a provider of in-home personal care services primarily for the elderly and disabled. No financial terms were disclosed. Also, Care Advantage has closed its buyout of its joint venture with Jefferson Area Board For Aging.

3 min read · 21 August 2018

Sverica acquires Gener8

Sverica Capital Management has acquired a majority stake in Sunnyvale, California-based Gener8, a maker of life science instruments. No financial terms were disclosed.

2 min read · 21 August 2018

New Water Capital acquires Trillium Health Care Products

New Water Capital acquired Trillium Health Care Products, which makes products for pharmaceutical companies. Trillium's existing management team will stay on, with General Manager Jay Webb becoming president. Trillium is New Water's tenth portfolio company since its fund closed in June 2015.

2 min read · 21 August 2018

Waud Capital inks partnership with healthcare exec

Waud Capital has teamed up with healthcare executive Chris Rucker to pursue investments in the home care market. Waud Capital has made an initial commitment of over $100 million to the effort. Previously, Rucker was a chief operating officer at Jordan Health Services.

3 min read · 20 August 2018

Gene therapy company Krystal Biotech raises $10 mln in private placement

Pittsburgh-based Krystal Biotech, a gene therapy company, has closed a private placement of $10 million. The buyer was Frazier Healthcare Partners. According to terms of the transaction, Krystal Biotech sold 625,000 shares of its stock at $16 per share. Chardan, an investment bank, served as the placement agent.

2 min read · 20 August 2018

PCP sells Medisys to TELUS

Persistence Capital Partners has sold Medisys Health Group Inc to TELUS Corporation. No financial terms were disclosed. Medisys is a Canadian provider of preventive and corporate healthcare solutions.

2 min read · 20 August 2018

Ember Therapeutics to divest OP-1 product family and related assets to Viscogliosi Brothers

New York City-based Ember Therapeutics, a biopharmaceutical company, has agreed to sell its OP-1 product family and related assets, to Viscogliosi Brothers LLC, a private equity firm focused on developing neuromusculoskeletal technologies. No financial terms were disclosed.

3 min read · 17 August 2018

GTCR to sell GreatCall to Best Buy for $800 mln

GTCR has agreed to sell GreatCall to Best Buy for $800 million. Based in San Diego, GreatCall is a provider of connected health and personal emergency response services for the elderly. The deal is expected to close in the third quarter of 2018. Raymond James was financial adviser to Great Call and GTCR while Kirkland & Ellis LLP was legal adviser.

3 min read · 15 August 2018

Showing 5,031 to 5,040 of 5,654 results
1…503505…566